Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372346
Status:
UNKNOWN
Last Update Posted:
2006-09-06
First Post:
2006-09-05
Brief Title:
Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial Hypertension
Sponsor:
Zhejiang University
Organization:
Zhejiang University
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2006-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Experimental data suggest that transplantation of endothelial progenitor cells EPCs attenuates monocrotaline-induced pulmonary hypertension in rats and dogs In addition clinical studies suggest that autogolous progenitor cells transplantation is feasible and safe in patients with ischemic disease This study will investigate the feasibility safety and initial clinical outcome of intravenous infusion of autologous EPCs in patients with idiopathic pulmonary arterial hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None